Medical Equipment and Services Companies Worldwide

Abionic, an in vitro diagnostics (IVD) company, was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL). Abionic is aiming to make a difference in patient care through the cutting-edge nanofluidic technology based ultra-rapid diagnostic platform, helping healthcare professionals to make clinical decisions at the point of care.

Aktiia – Bringing blood pressure monitoring to daily life Aktiia was founded in 2018 to commercialize its proprietary cuffless optical Blood Pressure Monitoring technology (oBPM™) in order to contribute to the prevention of high blood pressure, to save lives and to help reduce healthcare costs worldwide. aktiia is headquartered in Neuchatel (Switzerland) with offices opening up in Zurich (Switzerland) and the USA.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

"Amelia Virtual Care - formerly known as Psious - is an easy-to-use, fast and affordable virtual reality tool for mental health professionals. Founded in 2014, based in Mountain View, CA and Barcelona, Amelia supports psychologists and mental health professionals around the world who perform mental health assessments and interventions. It provides professionals with tools that can help them individualize and simplify processes for each and every individual.

Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges.

With Attolight, Cathodoluminescence (CL) is now available in a streamlined system which integrates CL with both light (LM) and electron microscopy (EM): what was a challenging experiment in the past, often done on klunky, home-made devices can now be done easily and efficiently. Attolight is now changing the landscape: its innovative approach brings nanometer resolution as well as pico-second timing for time-resolved studies, regardless of the wavelengths used. While any material that emits light under electron irradiation can be studied by CL, it is particularly valuable in material studies of semi-conductor materials, phosphor, ceramic, rock and glass. Combining LM, EM with hyperspectral imaging, Attolight’s solution reveals ultra-trace impurities and crystallographic defects not visible using other imaging modalities. Attolight "New Cathodoluminescence" solutions support the state-of-the -art research and developments in LEDs, Solar Cells, High Mobility Transitors, new opto-electronical devices, nano-structured semiconductors.

BIOCAPTIVA is developing the BioCaptis, a revolutionary medical device which has the potential to transform liquid biopsy testing for cancer management, by improving early diagnosis and monitoring of disease and enhancing clinical trial data of cancer patients. The BioCaptis captures up to 100x more cell free DNA (cfDNA) than a venous blood draw, yielding cfDNA in high quality and quantity for testing, addressing the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BIOCAPTIVA was founded in 2021 when it spun out from the University of Edinburgh. BIOCAPTIVA is based in Edinburgh and backed by Archangels Scottish Enterprise, Cancer Research Horizons, the new innovation engine of Cancer Research UK and Old College Capital, the University of Edinburgh’s in-house venture investment fund. For more information, please visit www.biocaptiva.com

biosurfit develops innovative medical diagnostic solutions in order to improve the performance and outcomes of physicians, by providing real-time and accurate results of blood analysis. Its core product is spinit®, a user-friendly instrument that combined with a disposable disc uses one small drop of blood to give precise results within minutes for multi-parameter test panels. spinit® will soon have the potential to perform a vast majority of blood tests combining cell and immuno-based diagnostics, with integrated sample preparation into the disposable disc. biosurfit will continuously develop different tests for the spinit® platform, addressing the physicians' needs.

New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine.

Endomag is a medical technology company devoted to improving the global standard of cancer care. Our Sentimag® probe, Magseed® marker and Magtrace® lymphatic mapping agent are already in use by many of the world’s leading physicians and cancer centres. Our goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. We’ve helped tens of thousands of women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), we continue to develop our unique clinical platform from our headquarters in Cambridge, United Kingdom.

EUCODIS Bioscience is a leading provider of novel industrial enzymes, with customers in the pharmaceutical, biotechnology, diagnostics, and other industries worldwide. With a portfolio of over 50 enzymes including innovative lipases, beta-lactamases, peroxidases and other enzymes EUCODIS Bioscience has a proven track record of providing customized enzyme solutions. In addition, EUCODIS Bioscience provides services ranging from enzyme engineering to process development as well as protein manufacturing according to our customers' individual specifications. EUCODIS Bioscience provides customized services in recombinant protein and enzyme production by covering the whole spectrum of bioprocess development up to industrial-scale manufacture of your target proteins under ISO9001. Our headquarters and main laboratories are located at the Campus Vienna Biocenter, Austria’s largest Biotech and University cluster.

Axiles Bionics is a new Brussels spin-off, from de Vrije Universiteit Brussel, developing the newest generation robotic ankle-foot prosthesis. Our mission is to improve the quality of life of amputees by bringing this newest bionic foot to the market.

We specialize in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions. Since launching as a spin-out from the University of Oxford in 2010, we have developed award-winning, AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.

For hospitals and clinics that aim to digitise their operations, BuddyCare is a mobile care coordination platform that automates patient pathway coordination. PATIENT EDUCATION - DATA COLLECTION - CARE COORDINATION - ANALYSIS Buddy Healthcare is on a mission to transform care coordination in hospitals and clinics by making care accessible and measurable for everyone, everywhere and anytime. BuddyCare App for Patients The BuddyCare App provides patients with all the information they need to navigate throughout the care process. It automates the workflow, communication, instructions, forms, and reminders so that patients are always aware of the next steps on the care path. The app is customised based on the care provider's needs so that it's always perfectly in-line with the patient processes and workflows. A white-label application is available with rapid delivery time for those care providers, who wish to have their own branded application. BuddyCare Dashboard for Care Personnel Through the BuddyCare Dashboard, care personnel has real-time visibility over patients’ preparation and recovery activities. The tool is used to collect, analyse and visualise patient data, which allows care personnel to focus on those patients most in need of attention. The system also uses data analytics to early predict risks for surgery no shows, and to find evidence-based best practices for patient pathways to improve the quality of care. Buddy Healthcare is a young Finland-originated company with a vision to transform pre and post-operative care. Visit our website https://www.buddyhealthcare.com/en/ or book a free online meeting with our expert.

Personal MedSystems is a pioneer in digital health. The company develops mobile diagnostic devices to enable the delivery of mobile healthcare. The CardioSecur product portfolio comprises mobile 12-lead ECG technologies that allow both patients and physicians to perform an instant heart check wherever they are. CardioSecur is the first and only mobile 22-lead ECG system with only 4 electrodes for physicians and patients. As easy to use personalized heart check for iPad/iPhone/iPod touch it enables patients at all times to gain certainty about their hearts‘ activity. Its instant evaluation of ischemic and rhythmic disorders and resulting direct recommendation allow patients to act swiftly and appropriately. Physicians do have the unique opportunity to perform precise diagnosis based on 22-lead ECG data from the moment of the cardiac event. So far an often insufficiently screened area.

Cardisio aims to sharply reduce unnecessary deaths, impaired quality of life, and medical expenses by providing an early heart disease screening to more people, more easily and with more accurate results. With these intentions, we developed Cardisiography, an AI-based 3D-vectorcardiography that allows for easy detection of pathological signs of arterial and structural heart diseases. Our innovative technology is much more exact than conventional first-line diagnostics and reaches a sensitivity of more than 90%. For more information about our product and company, please visit: https://cardis.io

CUREosity is a multiple international award-winning Med-Tec company located in Düsseldorf, Germany, that is changing rehabilitation by developing innovative therapy concepts. With our vision to revolutionize traditional rehabilitation we develop VR-based therapy applications and games to help people with neurological and mental disabilities. Change the world and become part of a unique collaboration between scientists, medical doctors, therapists, software developers and game designers. Together we develop completely new motion therapy systems - immersive instead of invasive. Impairments we aim to heal include stroke, craniocerebral trauma, MS, cerebral palsy, Parkinson's, paraplegia as well as dementia, depression, anxiety and pain therapy. With CUREO we developed our first smart software solution for innovative VR therapy that can be used immediately in any clinic. Grow with us! Give your daily work a deeper meaning and support us with your talent to help people with neurological and psychological disabilities. You can also benefit from being on board by growing with us personally and professionally, revolutionizing traditional rehabilitation. Became curious? Then follow or contact us on LinkedIn, visit our website and apply at jobs@cureosity.de!

Datacapt provides a global, easy-to-use, flexible, and powerful electronic data capture platform (EDC) for on-site, hybrid, or decentralized Clinical Trials. We allow Sponsors, CROs, and Subjects to work together in a simple way with a huge engagement. Our Platform brings simplicity, efficiency, and quality to the collection of clinical data. Datacapt is making the promise to simplify and accelerate clinical tests with innovative solutions. Simplify the management of your trial with the Datacapt platform. Developed with specialists and experts, our platform is flexible and adapted to your studies. We offer a modular platform with everything in one place to design and manage all your trials (EDC, eCRF, ePRO/eCOA/eDiary, eConsent, eConsult, and Data Analysis…). - Significantly reduced time spent on study setup and management (Simple and flexible eCRF, ePRO, eConsent creation) - Real-time monitoring - Allows reducing manual tasks, data retranscription, and zero time spent on data export - Fast and easy implementation - Secure and 100% Compliant

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal and accessible mental health support by combining evidence, cutting-edge tech and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. We deliver effective, accessible mental health support that adapts to their unique circumstances. Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com

We develop diagnostics that are fast, accurate and can be used at the point of care: ensuring the first prescription, is always the right prescription. Our technologies answer 2 vital questions to ensure effective and sustainable use of antibiotics: Does the patient have an infection treatable with antibiotics? NANOPLEX® is an advanced latex agglutination test that can be used to rapidly identify and quantify the cause of infection in 5 minutes. What will be the most effective antibiotic treatment? SCFI™ is a phenotypic, real-time and growth-free antibiotic susceptibility test that determines the most effective antibiotic in 30 minutes.

Founded by a powered wheelchair user, we create next-generation mobility products to allow wheelchair users to live the life they choose. The founder, Alex Papanikolaou, created Freedom One Life due to the limitations of the stagnant powerchair market which he experienced first-hand. Our vision is to deliver radical change to the market, offering a revolutionary powered wheelchair to improve independence and stretch the boundaries of powerchair users.

GlowDx is developing the Worlds First True Point-of-Care (POC) Diagnostics Platform, aimed at tackling Infectious Disease in Emerging Economies. Our first test detects mosquito-bourne infections (Dengue Fever, Chikungunya & Zika Virus), while our AI utilizes machine learning to model & predict future outbreaks.

Gradientech is a Swedish biotech and diagnostics company dedicated to support the modern microbiology lab with state-of-the-art solutions to facilitate the workflow with time-critical samples. Our product QuickMIC® is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument module analysing one sample against multiple antibiotics, well-suited for small and larger clinical laboratories. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST on the market. Gradientech’s technology combines microfluidics with live cell imaging to study cell responses in a linear concentration gradient. Our technology is a perfect match for many biological applications. Gradientech holds an ISO13485 certification.

ICONOVO AB is developing proprietary inhalation products for licensing. We have long experience and track record in the development of dry powder inhalers and offer a comprehensive range of devices to our clients. Our selection of device concepts for dry powder inhalation include a reservoir inhaler, a pre-metered inhaler, a capsule based inhaler and a single dose disposable inhaler. We can also provide formulation development, performance testing, documentation and a complete supply-chain.

Impulse Dynamics is dedicated to improving the lives of people with heart failure and is the developer of the innovative Optimizer®CCM® therapy delivery system. CCM® therapy is a breakthrough heart failure treatment that is proven to improve quality of life for heart failure patients. CCM® therapy is specifically designed to improve contraction of the heart in an effort to deliver more oxygen-rich blood to the body. CCM® therapy is a safe and effective minimally invasive treatment option for millions of heart failure patients who otherwise have few or no effective options available to them Optimizer was granted Breakthrough Device designation by the FDA and is the first and only FDA-approved device in the U.S. or elsewhere for the delivery of CCM® therapy. For important safety info visit: http://bit.ly/303mFRN

LiveMetric is a leader in continuous, wearable blood pressure monitoring for hypertension and cardiovascular disease. Through the development of proprietary sensor technologies coupled with AI insights, LiveMetric is the first cuffless, wearable, continuous BP monitor with accuracy highly correlated to the arterial line. And, is uniquely positioned as the only continuous monitor that does not require calibration and therefore can be implemented and sustained at home without ever having to visit to the providers office. The LiveMetric platform delivers hundreds of accurate BP measurements both day and night alongside heart rate, heart rate variability and steps taken. Providers will achieve real-time, personalized care and treatment for their patients through electronic transmission of the data to their medical records systems. The LiveMetric platform is part of a small, select group of blood pressure devices that are clinically validated for accuracy. Providers and users can rely on LiveMetric measurements the same as they would rely on arterial line measurements from the hospital. Through this level of accuracy our vision is to empower providers and patients with unparalleled data and actionable insights that will transform hypertension treatment and care resulting in better, healthier lives.

At LAVA, we are focused on applying our expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy. We refer to our compounds as gamma-delta bispecific T-cell engagers, or gamma-delta bsTCEs. Our platform generates therapeutics that specifically activate a unique and relatively abundant effector gamma-delta T-cell subset called Vγ9Vδ2 (Vgamma9-Vdelta2) T-cells that have the ability to trigger activity of immune cells of both the innate and adaptive immune system. Our gamma-delta bsTCEs have demonstrated superior efficacy and safety profiles compared to other bsTCE approaches in preclinical studies and show preferential activity against tumor cells thereby potentially limiting toxicity in healthy tissue. To date, we are the only company developing bispecific gamma-delta T-cell engaging antibodies for the treatment of cancer. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor specific antigen CD1d, which can be overexpressed in multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), among other tumor types. LAVA-051 will enter a Phase I/IIa study in 1Q21.

Vision: Global leadership in MedTech innovation for India and Global Markets Mission: Creating the world’s first portfolio of medical products, designed, engineered, and priced for Global Markets InnAccel identifies critical, unmet, healthcare needs, using the Stanford Biodesign process, and works on selected clinical needs with large global markets. The selected needs are taken forward to develop a regulatory-certified, world-class, product, deploying InnAccel’s proprietary Product Engineering & Development (PED) platform, in 2 – 3 years. InnAccel’s portfolio comprises 3 novel products addressing a global market of >$10 billion, and addresses conditions that lead to almost a million deaths in India alone each year. InnAccel has over 30 professionals (engineers, designers, clinicians) at its Innovation Center, led by a team that brings together entrepreneurial, technology development, and clinical experience. Our strategic advisory board includes industry leaders, and we have a network of 50+ advisors/ mentors to guide project teams. InnAccel is focused on transforming healthcare and attaining global leadership in medical technology for emerging markets, by 2025.

Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies.

Our mission is to radically improve early detection of brain disorders. We combine Virtual Reality and Artificial Intelligence to empower ophthalmologists and neurologists with reliable measurements of eye and pupil movements. Our goal is to bring the diagnostic quality of highly trained tertiary care specialists where it is needed most, in primary and secondary care. 🏆 Ypsomed Innovation Award 2022 🏆 IMD Startup Competition 2022/23 🚀 Massachusettes Innovation Network, Global Eddies 2023

We are a technology company operating at the intersection of medicine and technology. Our innovative solutions are revolutionizing the ways lives can be saved and patients can be treated. MedApp offers unique solutions to support diagnostic imaging and next-generation digital medicine. We are part of one of the fastest growing industries in the world. Our mission is to empower people for better health. Our product portfolio: 🔷 CarnaLife System: www.medapp.pl/en/carnalife-systems Innovative tool for in-depth remote health monitoring of patient 🔷 CarnaLife Holo: www.medapp.pl/en/carnalife-holo 3D imaging system enhancing precision, comfort and safety of medical procedures 🔷 HoloComm: www.medapp.pl/en/holocomm Perfect MR solution for remote 3D product demonstration 🔷 Digital Clinic: www.medapp.pl/en/carnalife-cyfrowa-przychodnia One-stop-shop for consultation, diagnosis and monitoring of patient's health

MedBeat is a medical technology company establishing a modern solution to accurately monitor your heart activity everywhere and anytime during your everyday life. We are developing medical devices and software, with the purpose of monitoring and enhancing cardiac health.

Our company is specialized in the repair and maintenance of surgical instruments, fixation of surgical instruments in silicone bars and selling a broad range of surgical instruments and medical products. We at Meekers Medical are convinced that the proper personal attitude and individual experience supplemented by a working method such as defined according to our ISO Quality system all contribute to the delivery of optimal service and quality.

Methinks vision is to provide universal and timely diagnosis for life-saving treatments worldwide. Our first focus is on stroke, the second cause of death and a major cause of disability in the world. Our product is an artificial intelligence medical imaging software capable of performing stroke triage and unlock stroke treatments potential from non-contrast CTs. Methinks is a VC backed digital health start-up that recently won the prestigious EIC Accelerator of the European Commission and has obtained two gold medals in the RSNA Kaggle competitions. The recent funding of the company will allow us to grow rapidly and we are looking for exceptional and passionate individuals to help us face these challenges and build together a unique company.

Micrima was founded in 2006 to develop and commercialise microwave radar breast imaging technology initially pioneered at the University of Bristol in the UK. The company's MARIA system is currently in clinical trials to collect valuable data for our machine learning algorithm's. The latest step in the journey to Breast Screening will be launched in 2022. This new system will provide density information and improved ergonomics for patient and operator. Contact us to arrange to see this system or to find out more.

MicroEJ is a software vendor of cost-driven solutions for embedded and IoT devices. With MicroEJ solutions, smart device manufacturers transform electronic products from single-purpose to software-defined, increasing scalability, flexibility, and extensibility. Our flagship product, MICROEJ VEE, is an optimized standard software container used in millions of consumer and IoT products, such as smart home devices, home appliances, wearables, medical devices, smart meters, and industrial devices. Our solutions are designed to provide the same capabilities as leading operating systems but with a much smaller footprint that can fit even the smallest processors, starting at $1 price point. With a team of over 70 employees in 6 offices worldwide, including the USA, France, Japan, Korea, Romania, and Germany, MicroEJ has a global presence and a proven track record of success. Over 200 million MICROEJ VEE IPs have been sold today, and we aim to reach a billion units in the upcoming years.

Minze Health is an Antwerp based HealthTech start-up that builds creative Digital Health solutions with a focus on Urology and Pelvic Health. Minze Homeflow enables the urologist to collect multiple uroflowmetries & voiding diary data in the comfort of the patients’ daily life and the allows the clinician to access this data in an online portal. Minze Hospiflow is a patient-friendly, flexible alternative for the current stationary uroflowmeters in hospitals or private practices. No more need for a dedicated space for uroflowmetry, Hospiflow can be used on any toilet!

Mobilis founded in 2018 as technology company that develops smart accessibility solutions for disabled people using modern AI technology. We are working on the 2 major projects: Mobilis Autopilot Solution for Electric Wheelchair -------------------------------------------------- The solution would enable several level of automation: from simple drive around obstacles and remote control to fully automatic drive inside an apartment. To attach Mobilis Autopilot to existing electric wheelchair we have created a Mobilis Connector solution. Details http://mobilis.io/wheelchairautopilot Mobilis Smart Sound Beacon -------------------------------------------------- Sound beacon is a navigation device for blind or visually impaired people. The device emits a periodic sound that allows a person with limited vision to locate the pace. These devices can be attached to doorways of buildings, public transport cabin doors, traffic lights, etc. The system is "last meters solution" and works on audible distances ~5..20m. Mobilis Sound beacons are silent, until they need by approaching blind user (No noise = no complaints from surrounding people). Details: http://mobilis.io/soundbeacon

Mode Sensors is a medical device company developing wearable sensor technology to support care providers and clinical decision-making.

Multiwave Technologies AG is a deep science technology company headquartered in Geneva, Switzerland. Founded in March 2015, Multiwave identifies market needs across industries and incubates metamaterial technologies to answer these needs with a view to improving living standards. Multiwave Innovation SAS, its wholly owned subsidiary based in France, develops medical devices to improve the quality of imaging in MRI. Assimilate SA, its wholly owned subsidiary based in Switzerland, uses quantitative portfolio analysis and sensors to assist retailers’ purchasing decisions and guide their overall marketing strategies to maximise profits. Other technologies in our portfolio include a microwave sensor to detect impurities in liquids as well as a trans-cranial magnetic stimulation device to treat neurological conditions. All our technologies are powered by proprietary software algorithms to accelerate engineering design.

MVision AI is a mission-oriented startup helping clinicians to save lives. MVision AI specializes in the field of medical imaging and artificial intelligence.

MX Labs is a deep-tech company. Our purpose is to help people stay healthy by providing camera-based holistic health assessment for early diagnostics and preventive medicine. We turn smartphones into diagnostics tools with camera-based technology Shen.AI that analyzes facial skin texture and extracts vital physiological signs in real-time. It applies remote photoplethysmography (rPPG) – a contactless optical measurement technique of recording faceblood pulsations at different vascular depths. Shen.AI scans human face in 60 seconds and provides vital signs such as: ☑️Heart Rate ☑️Heart Rate Variability (HRV) ☑️Respiratory Rate ☑️Blood Pressure ☑️SpO2 Measurement can be done on ordinary smartphones, tablets and computers equipped with camera. Additionally to camera measurements, Shen.AI provides a number of health risks, such as: Stress Index, Vascular Age or Cardiac Workload. Bring more value to your customers and grow your business by embedding easy and user-friendly vital signs analysis in your digital product. Allow your user to comprehensively monitor their vital signs. Check wellbeing and motivate lifestyle changes thanks to Shen.Al.

Nervtech is a high-tech R&D company specializing in vehicle simulator technologies in the fields of biometric and cognitive driver evaluation, machine learning and data integration. Nervtech’s patented 4DOF-motion compact driving simulator offers a real-life driving experience for simulator analytics and driver evaluation and training. The simulation can run on a configuration with three big external screens or with VR headset (Oculus Rift or HTC Vive). It can easily be moved transported to any location and set-up in a very short time. The simulation platform includes a variety of driving environments, from country side roads, snowy mountains, different highways and complex city centres. Unusual and dangerous behaviour can also be created providing critical and highly demanding driving situations and events. The platform provides also a set of ADAS elements (lane assist, emergency braking, adaptive cruise control, etc.) or fully autonomous driving. The cockpit of the driven vehicle is displayed on the screens and can be changed/modified freely to add new dashboard or IVIS elements (head-up display, dashboard display, different types of lights and indicators). External HW components can also be integrated into the system providing new types of input modalities. The platform includes also a set of physiological and biometrical medical grade sensors for measuring driver’s signals such as HR. GSR, body temperature, pupil diameter, gaze position, etc. Proprietary algorithms for detection of distraction, stress or cognitive workload are also provided. Nervtech’s main R&D goal is to develop techniques and procedures for the transfer of knowledge from human driver to self-driving machine. Consequentially autonomous vehicles will be able more efficiently handle complex and unpredictable driving situations by taking into account also human cognition and intuition-based decision-making.

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body.

NLC - the European Healthtech Venture Builder - is dedicated to advancing health, making it accessible for everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.

Noho wants to contribute to the happiness of people suffering from chronic diseases. We use at best and latest technologies and knowledge of the disease to get people with a chronic disease back to a normal life. Our connected bandage allows to reduce dynamically the lymphedema anywhere and at any time. Follow us to stay tuned.

NowTechnologies has been founded to undertake the development, design, marketing, manufacture and support of the GyroSet™ solution. Paralysis can be a life-changing condition, especially if the injury prohibits the person from going about their daily routine or job as maybe they previously did. Our goal is to provide these people with an affordable solution that can make them independent and enable them to live their lives with mobility and through providing a way to interact with computers again, providing them with the potential to work, create and communicate. Our solution has been developed with the active participation of injured and disabled users whose requirements and feedback was invaluable in bringing Gyroset™ to completion.